122 related articles for article (PubMed ID: 3052842)
1. Management of bacterial and fungal infections in bone marrow transplant recipients and other granulocytopenic patients.
Heidt PJ
Cancer Detect Prev; 1988; 12(1-6):609-19. PubMed ID: 3052842
[TBL] [Abstract][Full Text] [Related]
2. Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation.
Vossen JM; Heidt PJ; van den Berg H; Gerritsen EJ; Hermans J; Dooren LJ
Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):14-23. PubMed ID: 2105890
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal decontamination of dogs treated with total body irradiation and bone marrow transplantation.
Vriesendorp HM; Heidt PJ; Zurcher C
Exp Hematol; 1981 Oct; 9(9):904-16. PubMed ID: 7040095
[TBL] [Abstract][Full Text] [Related]
4. New approaches to the prophylaxis and treatment of bacterial and fungal infections in allogeneic marrow transplant recipients.
Schuler U; Ehninger G
Bone Marrow Transplant; 1994; 14 Suppl 4():S61-5. PubMed ID: 7728128
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.
Winston DJ; Ho WG; Bartoni K; Champlin RE
Bone Marrow Transplant; 1993 Sep; 12(3):283-8. PubMed ID: 8241988
[TBL] [Abstract][Full Text] [Related]
6. Effects of bacterial naso-oropharyngeal colonisation on acute graft-versus-host disease in patients undergoing allogeneic bone marrow transplantation.
Liu KL; Herbrecht R; Lioure B; Jaulhac B; Maloisel F; Dufour P; Bergerat JP; Oberling F
Bone Marrow Transplant; 1995 Jan; 15(1):65-9. PubMed ID: 7742757
[TBL] [Abstract][Full Text] [Related]
7. Acute graft-versus-host disease after allogeneic bone marrow transplantation.
Perreault C; Gyger M; Boileau J; Bonny Y; Cousineau S; Lacombe M; Lavallee R; Tawil E; D'Angelo G
Can Med Assoc J; 1983 Nov; 129(9):969-74. PubMed ID: 6367917
[TBL] [Abstract][Full Text] [Related]
8. Infections in bone marrow transplant patients: use of reverse-barrier isolation.
Pretnar J; Cernelc P; Mlakar U
Transplant Proc; 1992 Oct; 24(5):2033. PubMed ID: 1412961
[No Abstract] [Full Text] [Related]
9. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial prophylaxis in neutropenic patients after bone marrow transplantation.
Schmeiser T; Kurrle E; Arnold R; Krieger D; Heit W; Heimpel H
Infection; 1988; 16(1):19-24. PubMed ID: 3283035
[TBL] [Abstract][Full Text] [Related]
14. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
[TBL] [Abstract][Full Text] [Related]
15. Infectious complications of bone marrow transplantation.
Winston DJ; Ho WG; Champlin RE; Gale RP
Exp Hematol; 1984 Mar; 12(3):205-15. PubMed ID: 6368256
[No Abstract] [Full Text] [Related]
16. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
Yee GC; McGuire TR
Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
[TBL] [Abstract][Full Text] [Related]
17. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
Vossen J
Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
[TBL] [Abstract][Full Text] [Related]
19. [Infections following bone marrow transplantation].
Ljungman P; Andersson J; Sparrelid E
Nord Med; 1995; 110(12):320-1. PubMed ID: 8524635
[TBL] [Abstract][Full Text] [Related]
20. Infections in allogeneic bone marrow transplant recipients.
Wingard JR
Semin Oncol; 1993 Oct; 20(5 Suppl 6):80-7. PubMed ID: 8211220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
